Takashi Nakahara Selected Research

Takashi Nakahara Research Topics

Disease

46	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 01/2012
22	Fibrosis (Cirrhosis) 07/2022 - 07/2013
18	Infections 02/2022 - 11/2013
18	Neoplasms (Cancer) 08/2021 - 08/2012
16	Chronic Hepatitis C 01/2021 - 12/2014
15	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 06/2015
10	Non-alcoholic Fatty Liver Disease 01/2022 - 02/2014
7	Liver Diseases (Liver Disease) 03/2022 - 02/2014
7	Chronic Hepatitis B 01/2021 - 01/2016
6	Hepatic Encephalopathy 11/2020 - 07/2013
5	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2018
5	Thrombosis (Thrombus) 04/2021 - 06/2015
5	Inflammation (Inflammations) 06/2020 - 04/2010
5	Disease Progression 04/2020 - 04/2011
4	Hepatitis B 01/2021 - 03/2017
3	Sarcopenia 02/2020 - 10/2018
3	Dyslipidemias (Dyslipidemia) 08/2019 - 11/2012
3	Hemorrhage 01/2018 - 11/2015
2	Insulin Resistance 03/2022 - 02/2014
2	Alcoholic Fatty Liver 07/2021 - 11/2012
2	Wounds and Injuries (Trauma) 01/2021 - 11/2015
2	Hepatitis 01/2021 - 12/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2018
2	Necrosis 01/2021 - 01/2018
2	Microsatellite Instability 10/2020 - 07/2020
2	Hepatitis C 09/2020 - 12/2014
2	Edema (Dropsy) 02/2020 - 08/2016
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 12/2018
2	Lymphatic Metastasis 08/2019 - 08/2012
2	Anemia 06/2017 - 11/2016
2	Critical Illness (Critically Ill) 06/2010 - 01/2009
2	Heat Stroke (Heatstroke) 04/2010 - 01/2009
1	Fatty Liver 07/2022
1	Hypoglycemia (Reactive Hypoglycemia) 03/2022
1	Hyperglycemia 03/2022

Drug/Important Bio-Agent (IBA)

16	lenvatinibIBA 04/2022 - 01/2019
13	Antiviral Agents (Antivirals)IBA 02/2022 - 08/2016
13	InterferonsIBA 11/2020 - 07/2013
12	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2012
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
8	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 12/2014
6	AntigensIBA 01/2021 - 11/2016
6	daclatasvirIBA 01/2020 - 08/2016
6	asunaprevirIBA 01/2020 - 08/2016
5	Hemoglobins (Hemoglobin)IBA 03/2022 - 05/2009
5	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 11/2014
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 12/2017
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2014
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 03/2017
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2009
5	SofosbuvirIBA 11/2020 - 06/2017
5	CytokinesIBA 01/2020 - 01/2009
4	Pharmaceutical PreparationsIBA 01/2022 - 08/2019
4	Alanine Transaminase (SGPT)IBA 01/2021 - 03/2014
4	regorafenibIBA 01/2021 - 09/2018
3	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 08/2012
3	Bevacizumab (Avastin)FDA Link 04/2022 - 08/2021
3	atezolizumabIBA 04/2022 - 08/2021
3	Blood Glucose (Blood Sugar)IBA 03/2022 - 01/2017
3	EnzymesIBA 02/2021 - 10/2019
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 11/2016
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
3	Fetal Proteins (Fetoprotein)IBA 11/2020 - 01/2012
3	NucleosidesIBA 01/2019 - 01/2018
3	NucleotidesIBA 01/2019 - 01/2018
3	HMGB1 Protein (HMG1)IBA 01/2018 - 12/2009
2	Carrier Proteins (Binding Protein)IBA 01/2022 - 09/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 11/2012
2	Immune Checkpoint InhibitorsIBA 02/2021 - 10/2020
2	glecaprevir and pibrentasvirIBA 01/2021 - 01/2020
2	Prothrombin (Factor II)IBA 01/2021 - 12/2017
2	pembrolizumabIBA 10/2020 - 07/2020
2	nasIBA 08/2020 - 06/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2020 - 01/2009
2	pibrentasvirIBA 04/2020 - 03/2019
2	glecaprevirIBA 04/2020 - 03/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 05/2016
2	BilirubinIBA 10/2019 - 12/2017
2	AmmoniaIBA 08/2019 - 01/2019
2	ChemokinesIBA 07/2019 - 01/2018
2	ledipasvirIBA 12/2018 - 11/2017
2	Interleukin-8 (Interleukin 8)IBA 12/2018 - 12/2009
2	entecavir FDA Link 12/2018 - 01/2018
2	sofosbuvir drug combination ledipasvirIBA 04/2018 - 11/2017
2	danaparoid (Orgaran)FDA Link 01/2018 - 06/2015
2	Oxygen (Dioxygen)IBA 01/2018 - 04/2016
2	telaprevirIBA 12/2014 - 12/2014
2	Superoxides (Superoxide)IBA 11/2010 - 04/2010
1	Capsules (Microcapsules)IBA 07/2022

Therapy/Procedure

43	Therapeutics 06/2022 - 11/2010
12	Drug Therapy (Chemotherapy) 06/2022 - 08/2012
7	Radiotherapy 04/2021 - 08/2012
4	Liver Transplantation 01/2021 - 03/2017
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2019 - 07/2013
3	Resuscitation 10/2016 - 01/2015
2	Bariatric Surgery 01/2022 - 07/2021
2	Hepatectomy 08/2019 - 08/2012
2	Artificial Respiration (Mechanical Ventilation) 11/2010 - 06/2010
1	Glycemic Control 03/2022